Analysis of Clinical Trial Management Systems market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global clinical trial management systems market is projected to garner a valuation of around US$ 1.3 Bn in 2022.
Deployment of clinical trial management systems are slated to accelerate at a high CAGR of 13.6% to top US$ 4.6 Bn by 2032. Demand for web-based clinical trial management systems is expected to witness expansion at a CAGR of 13.9%.
Clinical Trial Management Systems Market Size (2022)
US$ 1.3 Bn
Market Forecasted Value (2032)
US$ 4.6 Bn
Global Growth Rate (2022-2032)
Market Share of Top 5 Companies
15% - 20%
The global healthcare IT market was valued at around US$ 210 Bn in 2020, in which, clinical trial management (CTM) systems held a market share of 0.5%. Increasing investments by biotechnology and pharmaceutical companies coupled with funding from government is endorsing research activities. This factor is anticipated to boost growth of the market for clinical trial management systems 3.6x by 2032.
Technical advancements have also boosted demand for clinical trial management systems, as per Fact.MR, a market research and competitive intelligence provider. For instance, the AMC (Asan Medical Center) in Seoul, South Korea established a new system that is adept to dealing data of clinical trial images from group to extraction. This is likely to be a major revolution in CTM systems, as this could make clinical trials more efficient and faster than ever before.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
End users have often a misplaced, exaggerated notion about the security apparatus of clinical trial management systems. Pharmaceutical companies and hospitals make notable investments in handling clinical trials. Data produced post-clinical trials is crucial, and demand for CTMS is expected to surge for ease of information management.
Although vendors have made investments for the betterment of the security apparatus of web-based cloud security models, a concerted effort from all stakeholders is necessary if web-based clinical trial systems are to experience further penetration. Pharmaceutical and clinical research organizations (CROs) are key shareholders in the market.
Keeping track of clinical studies is the key reason for the demand for CTMS. The clinical profession currently facing issues with prior roles while working on multiple clinical trials. The major issue is with handling information and reports. The CTMS solutions are likely to improve the speed and transparency of data management.
CTMS allows collaboration for members where the team can work and learn together. The planning, tracking, and monitoring features of this system enhance user experience and performance.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Considering the slew of advantages that clinical trial management systems have over traditional systems, the future belongs to software in the component segment of clinical trial management systems. Advancement in clinical trial management systems has been undergoing since recently, and software based now account for a majority share in the market.
The software segment holds a market share of nearly 83% and is likely to experience a growth rate of 13.9% CAGR through 2032.
The researchers can collect data insights from real-world shreds of evidence through a variety of ePRO, eCOA, and clinical databases. Data harmonization achieved with CTMS likely to increase clinical data analytics in the forecast period.
Investment in R&D to Grow the Market in North America
The U.S. is likely to dominate the North America clinical trial management systems market with an estimated market share of more than 85% in 2022. Steady growth of pharmaceutical companies, clinical research organizations, and healthcare organizations, coupled with surge in investments in technical innovation, is supporting growth of the U.S. market.
Regulatory compliance holds a crucial stake in getting approval for CTMS. The system should abide by the 21 CFR Part 11 compliance for electronic records and signatures prescribed by the Food and Drug Association of the USA.
The growing investment in R&D is expected to augment the regional market. As per Pharmaceutical Research and Manufacturers of America, in 2018, the biopharmaceutical industry invested nearly USD 102 billion in R&D. Furthermore, the growing number of studies and clinical trials can boost the market in the coming time. Overall, North America will likely contribute 33% of the revenue pie.
Increasing Development of Pharmaceutical Drugs to Boost Market in Germany
The Germany market is estimated for a valuation of more than US$ 60 Mn in 2022. Factors such as increasing investments in research & development with rise in demand for the development of drugs are sustaining the growth of the market.
As healthcare infrastructure in Germany is robust and open to any technological abruption, the market for clinical trial management systems in the country is set to grow at high pace.
The robust healthcare and accurate information offered by the clinical trial management system is projected to augment the market size in Europe. Further, the growing medical research towards rare disease and multiple orphan drugs is another important cause that can aid to develop the regional market.
Increasing initiatives by the government of various countries have encouraged the small, medium, and large players to develop orphan drug development. Also, the orphan drug hold significant lucrative market opportunities to the established pharmaceutical players.
The statutory measures in Germany and the active role of government in the health sector. Health insurance is mandatory in Germany making it with 86% of the population already enrolled the same. Inpatient, outpatient, and prescription drug coverage are included in it. The extensive use of technology in healthcare.
Increasing Investment by Government to Develop Clinical Trial Market
The market in East Asia valued at US$ 240 Mn in 2021. The region is expected to hold significant market opportunities owing to the growing investment by the governments of various countries for the advancement of clinical trials.
Further, lesser stringent rules in the region as compared to developed nations is projected to be another potent cause that can strengthen the market. Also, low operating cost and increasing number of pharmaceutical companies in the region can additionally burgeon the regional market size.
Real Time Access to Information to Boost the Segment
Demand for web-based clinical trial management systems has witnessed a remarkable increase in the last five years. Real-time access to information and quick analysis of results are likely to boost the demand for the same. Further, the virtual storage option has proven to be economical to the pharmaceuticals and biotechnology companies.
The web-based clinical trial management systems accounted for about 68% of the market revenue share in 2020. The flexibility, affordability, and advanced technology make web-based clinical trial management the preferred deployment model for end users; however, challenges persist. This leads the web-based mode of deployment to be valued at US$ 3.2 Mn by the end of forecast period. Preference for web-based clinical trial management systems is likely to continue during the assessment period as well. The transition to web-based clinical trial management also gives end users the tools to centralize computational and research tools.
However, the clinical trial industry faces reluctance owing to issues such as privacy and data security. Availability of cloud-based products and platforms that can utilize big data technology to optimize the cost of clinical trial management systems can reduce some level of uncertainty.
Due to the COVID-19 pandemic, medical practices are under massive pressure; suppliers across the globe have been stunned by the increasing and large number of patients. Rise of this outbreak has led to financial restraints on pharma companies across numerous countries.
The recent pandemic saw a great moment in terms of clinical trials for the Covid-19 Vaccine. As per NBC about 30,000 people from the united states participated in the vaccine trial run by Moderna company. The pandemic has further brought drug discovery and clinical trials into a mainstay.
In this regard, clinical trial management systems have proven to be very supportive, as they allow academic & industrial researchers to observe patients by using digitally connected platforms to evaluate and organize clinical data for regulatory proposals.
The COVID-19 outbreak has also amplified the need for social distancing among patients and physicians, which has driven demand for digital solutions and remote patient monitoring for clinical research analysis and data gathering. Many key players in the market have launched COVID-19-associated features into their existing systems, which are being made available for free of cost to users.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
Majority of companies are focused on expansions, investments, acquisitions, delivery, portfolio expansion, and brand development. Key players also have a strong position in the global market with a large set of customers, which springs them with an edge over their competitors in the market.
Moreover, developers also participate comprehensively in campaigns of advertising to surge their visibility in the field. Major players are fluctuating their focus toward platforms with smart services to allow patients to operate their products remotely.
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Related Reports -
The global clinical trial management systems market is estimated to hold a value of USD 1.3 Bn in 2022.
The global market is projected to surge at a CAGR of 13.6% during 2022 – 2032.
Dollar value of clinical trial management systems increased at a CAGR of 10.2% during 2017 – 2021.
Rising number of clinical trials due to large demand for medical devices and novel therapeutic drugs is the driving force for this market.
Top 5 countries driving demand for clinical trial management systems are the U.S., China, Canada, Germany, India, and Japan.
East Asia accounted for more than 19% of the global market share in 2020.
The European market for clinical trial management systems is projected to expand at a CAGR of 12.7% during the forecast period from 2022-2032.
Need An Exclusive Report For Your Unique Requirement?